← Leaderboards
Jaehwan Kim
University Of California At Davis
$677,429
Attributed
$677,429
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $170.6K · FY2022–25$200K$150K$100K$50K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$677,429 · 1
By mechanism
K23$677,429 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California At Davis
Same institution · by research overlap
- Melissa Dawn Bauman$11,484,594
- Pier Giuseppe Pelicci$1,325,251
- Alexander Nord$7,110,394
- Lisa A Miller$6,445,510
- Maija Helena Tuulia Kiuru$1,000,200
Others in their field
Other Rising Stars on “Drug Clearance”
- Jeff T Hutchins · Inhalon Biopharma, Inc.$10,784,260
- Robert C Alexander · Banner Health$5,101,602
- Farshad Tehrani · Actiox Llc$3,351,618
- Justin Blaine Schaal · University Of Southern California$3,025,760
- Matt Devalaraja · Protean Bio Inc.$2,995,006
- Swetha Gowrishankar · University Of Illinois At Chicago$2,350,354
Research focus
Drug ClearanceDisease RemissionDoseAnatomyBiologicalAntibodiesBiological ProductsAntigen-Presenting CellsBiopsy SpecimenCd4 Positive T LymphocytesCd8-Positive T-LymphocytesCell CommunicationCellsBiological MarkersChromatinChronic Inflammatory DiseaseClinical ApplicationClinical TrialsCombinatorialCytokineDendritic CellsDigestionDisease ProgressionEnzymes
Grant awards (5)
A clinical trial for psoriasis with novel single-cell genomic techniques to understand regulatory immunity behind long-term disease remission off drug induced by short-term IL-23 inhibition$168,948
K23 · FY2025 · AR · contact PI
A clinical trial for psoriasis with novel single-cell genomic techniques to understand regulatory immunity behind long-term disease remission off drug induced by short-term IL-23 inhibition$1,637
K23 · FY2025 · AR · contact PI
A clinical trial for psoriasis with novel single-cell genomic techniques to understand regulatory immunity behind long-term disease remission off drug induced by short-term IL-23 inhibition$168,948
K23 · FY2024 · AR · contact PI
A clinical trial for psoriasis with novel single-cell genomic techniques to understand regulatory immunity behind long-term disease remission off drug induced by short-term IL-23 inhibition$168,948
K23 · FY2023 · AR · contact PI
A clinical trial for psoriasis with novel single-cell genomic techniques to understand regulatory immunity behind long-term disease remission off drug induced by short-term IL-23 inhibition$168,948
K23 · FY2022 · AR · contact PI